Advanced Pancreatic Carcinoma
Oncology·MeSH: Pancreatic Neoplasms
3 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
| Drug | Company |
|---|---|
| Olaparib | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| HCW9218 | ImmunityBio, Inc. (IBRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Advanced Pancreatic Carcinoma?
BioSniper tracks 3 drugs in development for Advanced Pancreatic Carcinoma across 2 companies.
How many clinical trials target Advanced Pancreatic Carcinoma?
There are 3 clinical trials targeting Advanced Pancreatic Carcinoma tracked by BioSniper.
Deep-dive into Advanced Pancreatic Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis